Clinical Trial Update: A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating belinostat in combination with carboplatin and/or paclitaxel in relapsed ovarian cancer; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Epithelial Ovarian Cancer
• Fallopian Tube Cancer
• Ovarian Cancer

Drugs mentioned

• BELEODAQ (BELINOSTAT)
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Valerio Therapeutics | Conditions: Ovarian Cancer, Epithelial Ovarian Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-12-15